Fig. 2: Quantitative sensory testing (QST) outcomes. | Neuropsychopharmacology

Fig. 2: Quantitative sensory testing (QST) outcomes.

From: Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain

Fig. 2: Quantitative sensory testing (QST) outcomes.

Data show results from the cold pressor task (top) and global QST measures (bottom), as a function of study condition (x-axis). Medication conditions were Placebo + Placebo (Plc + Plc), oral hydromorphone 4 mg + placebo (Hydro + Plc), and hydromorphone 4 mg combined with oral dronabinol 10 mg (Hydro + Drnb). Line that connect bars represents a significant difference in post-hoc comparison and error bars represent SEM.

Back to article page